Loading data for WHWK — first visit, this takes a few seconds.

알림

Whitehawk Therapeutics In... (WHWK)

NasdaqCM: WHWK · 실시간 가격 · USD

4.62

-0.25 (-5.13%)

종가 기준: Aug 28, 2026, 3:59 PM

4.62

+0.00%

애프터마켓: 7:30 PM

주가와 핵심 숫자, 최신 뉴스를 한 곳에 모았습니다.

-5.13% (1D)

매수호가	4.61
시가총액	263.38M
매출 (ttm)	n/a
순이익 (ttm)	-79.83M
	0.78
	-1.15
	n/a
	-4.68
P/B (ttm)	1.88
P/S (ttm)	n/a
실적 발표일	Nov 5, 2026

매도호가	5.91
거래량	96,991
평균 거래량 (20일)	461,340
시가	4.87
전일 종가	4.87
일중 범위	4.60 - 5.03
52주 범위	1.76 - 5.50
애널리스트	n/a
목표주가	n/a
배당	n/a
배당락일	n/a

WHWK 소개

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in M...

[더 보기]

산업 Biotechnology

섹터 Healthcare

IPO 일자 Feb 16, 2018

직원 수 32

상장 거래소 NasdaqCM

티커 WHWK

웹사이트 https://ir.whitehawktx.com

전체 기업 정보

재무 실적

2025년 Whitehawk Therapeutics의 매출은 7.14M로, 전년 25.98M 대비 -72.5% 감소했습니다. 순이익은 -20.6M로, -67.66% 감소했습니다.

재무제표

어닝 서프라이즈

Whitehawk Therapeutics가 Aug 5, 2026에 분기 실적을 발표했습니다:

매출 $0 예상치 하회 $0, 및 NaN% 전년 대비 성장.
EPS -0.2 예상치 상회 0.06, 및 73.68% 전년 대비 성장.

다음 실적 발표

Whitehawk Therapeutics Inc.의 실적 발표 예정일은 Nov 5, 2026, 장 시작 전입니다.
애널리스트 예상 매출은 ... 업그레이드

뉴스

1일 전 · Zacks

What Makes Whitehawk Therapeutics, Inc. (WHWK) a Strong Momentum Stock: Buy Now?

Does Whitehawk Therapeutics, Inc. (WHWK) have what it takes to be a top stock pick for momentum investors? Let's find out.

3일 전 · Zacks

Wall Street Analysts Predict a 47.64% Upside in Whitehawk Therapeutics, Inc. (WHWK): Here's What You Should Know

The mean of analysts' price targets for Whitehawk Therapeutics, Inc. (WHWK) points to a 47.6% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agr...

2개월 전 · Insider Monkey

Is Whitehawk Therapeutics (WHWK) One Of The Hot Biotech Stocks Under $5 To Buy?

Whitehawk Therapeutics, Inc. (NASDAQ:WHWK), featuring a year-to-date gain of 71.49% and upside potential of 68.70%, secures a spot on our list of hot biotech stocks under $5 to buy. A busy period of p...

3개월 전 · Motley Fool

Acuta Capital Sells 56% of Ocular Therapeutix Shares in Q1

Ocular Therapeutix delivers FDA-approved eye therapies and devices, supported by a pipeline targeting multiple ocular diseases.

3개월 전 · Stocktwits

WHWK Stock Edges Up After Hours: Firm Boosts Pipeline Of Cancer Drugs On The Heels Of Capital Raise

Whitehawk said it has secured rights from Hangzhou DAC to use the CPT113 linker-payload technology in up to five additional internally developed programs.

2 페이지 중 1